
Robert Booth PhD
Founder and Chief Executive Officer
Robert Booth PhD
Chief Executive Officer, Virobay
Robert Booth was the driving force behind the creation of Virobay in 2006. While he was the Executive Chairman of Virobay, Inc. from 2006 to 2010, he concurrently served as an Operating Partner and Senior Advisor at TPG Biotech, a venture capital company.
Previously, he was Chief Scientific Officer at Celera Genomics, responsible for integrating and leading Celera's therapeutic discovery and development activities. The therapeutic areas pursued by Celera included oncology, autoimmunity, respiratory diseases and thrombosis.
Robert also served in a series of executive positions at Roche for over 13 years, including Senior Vice President responsible for research and early development in the therapeutic areas of inflammation, autoimmunity, virology, respiratory diseases, transplantation and bone disease products. Robert was a member of the Global Research Management Team and a member of the Business Development Committee, which oversaw licensing opportunities for Roche. During his time at Roche, Robert managed R&D organizations in both the US and Europe.
Robert serves on the board of Pharmacyclics Inc. He is a board observer and Chairman of the Science Advisory Board of Galleon Pharmaceuticals. He is also a member of the Science Advisory Boards of ShangPharma ChemPartner and Elcelyx. Additionally, he serves as a consultant to a number of biotech and venture capital groups.
Robert obtained his B.Sc. and Ph.D. from the University of London in the field of biochemistry.